- Division of Neuroscience, Development and Aging – DNDA
- Biology of Development and Aging – BDA
- Study Section:
- International and Cooperative Projects-1 – ICP1
Dr. Seetha Bhagavan is within the NIH’s Center for Scientific Review as its Fogarty and International Peer Review Coordinator and the Scientific Review Officer for the International and Cooperative Projects -1 [ICP1] study section. She received her Ph.D in Neurobiology at The Ohio State University, where she investigated the GABA-mediated physiological and behavioral mechanisms underlying learning and memory. Her postdoctoral research at Georgetown University, examining cellular and molecular aspects of memory and its role in Alzheimer’s Disease (AD), led to the discovery of a potential diagnostic biomarker for this disease. Consequently, she helped set-up and run a biotechnology firm in Rockville, Maryland. As the Senior Scientist and Diagnostic Director of Neurologic, Inc., she directed a multi-center, FDA-regulated clinical study to validate a diagnostic test for AD, and also coordinated research projects to develop new therapeutic avenues for this disease. Since joining CSR in January 2004, Dr. Bhagavan has helped reorganize two study sections within BDCN—Cell death, Injury and Neurodegeneration (CDIN) and Clinical Neuroscience and Disease (CND). She has since created and has coordinated four chartered committees between 2005-present: Acute Neural Injury and Epilepsy (ANIE), Brain Injury and Neurovascular Pathologies (BINP), Clinical Neuroscience and Neurodegeneration (CNN) and ICP1. In 2011, she conducted a 2-stage NIH editorial board review for the US (NIH)-India Bilateral Brain Research Collaborative Partnership. Between 2012-2016, she also led the trans-NIH review for the Opportunities for Collaborative Research between extramural and intramural scientists at the NIH Clinical Center. In 2017, she devised a 3-stage editorial board peer review process to lead the first joint peer review between NIH and other member agencies of the Global Alliance for Chronic Diseases (GACD) of applications on Implementation Science for the Prevention and Treatment of Mental and/or Substance Use Disorders in Low- and Middle-income Countries (LMIC).